All Clinical Trials in Canada

A listing of 3905 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

Canada

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

International CIPN Assessment and Validation Study

NCT04633655

Recruiting

This is an observational study of chemotherapy-induced peripheral neurotoxicity (CIPN) patients to be investigated prospectively in order to assess responsiveness of a set of outcome measures in an international multi-center study.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/24/2025

Locations: Birmingham School of Nursing, University of Alabama, Birmingham, Alabama +29 locations

Birmingham School of Nursing, University of Alabama, Birmingham, Alabama

Northside Hospital, Atlanta, Georgia

JHU, Baltimore, Maryland

University of Michigan School of Nursing, Ann Arbor, Michigan

Columbia University Irving Medical Center, New York, New York

Cancer Center/Wexner Medical Center - Ohio State Medical Oncology Division, Columbus, Ohio

Dartmouth-Hitchcock Medical Center, Lebanon, Pennsylvania

University of Vermont Medical Center, Burlington, Vermont

Brain and Mind Center, Sidney, Not set

Dept. of Neurology, Medical University of Vienna, Vienna, Not set

International Centre for Diarrhoeal Disease Research, Dhaka, Not set

Clínica AMO, Salvador, Not set

The Ottawa Hospital, Ottawa, Not set

Aarhus University Hospital, Aarhus, Not set

Hôpital Percy, Clamart, Not set

CHU Dupuytren, Limoges, Not set

Center for Molecular Medicine, Cologne, Not set

University of Larissa, Larissa, Not set

"Saint Andrew's" State General Hospital, Patras, Not set

San Gerardo Hospital, Monza, Mb

Ospedale Valduce, Como, Not set

Ospedale Policlinico San Martino, Genova, Not set

A.O.U. Policlinico "G. Martino", Messina, Not set

Padova Hospital, Padova, Not set

Azienda Ospedaliera Universitaria, Verona, Not set

Medical Oncoloy Unit - University of Nairobi, Nairobi, Not set

Dong-A University - Internal Medicine Dept., Busan, Not set

Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Not set

Hospital Universitari de Bellvitge-ICO L'Hospitalet, Barcelona, Not set

University of Basel - Department of Sport, Exercise and Health, Basel, Not set

Conditions: Chemotherapy-induced Peripheral Neuropathy, Quality of Life

Learn More ›

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

NCT03816345

Recruiting

This phase Ib trial studies the side effects of nivolumab and to see how well it works in treating patients with autoimmune disorders and cancer that has spread to other places in the body or cannot removed by surgery. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/24/2025

Locations: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama +51 locations

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama

Stanford Cancer Institute Palo Alto, Palo Alto, California

University of California Davis Comprehensive Cancer Center, Sacramento, California

Smilow Cancer Center/Yale-New Haven Hospital, New Haven, Connecticut

Yale University, New Haven, Connecticut

MedStar Georgetown University Hospital, Washington, District of Columbia

Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia

Northwestern University, Chicago, Illinois

University of Chicago Comprehensive Cancer Center, Chicago, Illinois

University of Kansas Clinical Research Center, Fairway, Kansas

HaysMed, Hays, Kansas

University of Kansas Cancer Center, Kansas City, Kansas

Lawrence Memorial Hospital, Lawrence, Kansas

The University of Kansas Cancer Center - Olathe, Olathe, Kansas

University of Kansas Cancer Center-Overland Park, Overland Park, Kansas

University of Kansas Hospital-Indian Creek Campus, Overland Park, Kansas

Mercy Hospital Pittsburg, Pittsburg, Kansas

Salina Regional Health Center, Salina, Kansas

University of Kansas Health System Saint Francis Campus, Topeka, Kansas

University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas

University of Kentucky/Markey Cancer Center, Lexington, Kentucky

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland

National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland

National Institutes of Health Clinical Center, Bethesda, Maryland

Massachusetts General Hospital Cancer Center, Boston, Massachusetts

Dana-Farber Cancer Institute, Boston, Massachusetts

Wayne State University/Karmanos Cancer Institute, Detroit, Michigan

Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri

University Health Truman Medical Center, Kansas City, Missouri

University of Kansas Cancer Center - North, Kansas City, Missouri

University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri

University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City, Missouri

Washington University School of Medicine, Saint Louis, Missouri

Siteman Cancer Center-South County, Saint Louis, Missouri

Siteman Cancer Center at Christian Hospital, Saint Louis, Missouri

Siteman Cancer Center at Saint Peters Hospital, Saint Peters, Missouri

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

NYU Langone Hospital - Long Island, Mineola, New York

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York

NYP/Weill Cornell Medical Center, New York, New York

Ohio State University Comprehensive Cancer Center, Columbus, Ohio

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania

UT Southwestern Simmons Cancer Center - RedBird, Dallas, Texas

UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas

UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth, Texas

M D Anderson Cancer Center, Houston, Texas

UT Southwestern Clinical Center at Richardson/Plano, Richardson, Texas

Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah

Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia

University Health Network-Princess Margaret Hospital, Toronto, Ontario

Conditions: Autoimmune Disease, Crohn Disease, Dermatomyositis, Inflammatory Bowel Disease, Multiple Sclerosis, Rheumatoid Arthritis, Sjogren Syndrome, Systemic Lupus Erythematosus, Systemic Scleroderma, Ulcerative Colitis, Hematopoietic and Lymphoid Cell Neoplasm, Psoriasis, Psoriatic Arthritis, Malignant Solid Neoplasm

Learn More ›

A Study to Evaluate the Efficacy and Safety of Frexalimab, SAR442970, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

NCT06500702

Recruiting

This is a parallel, Phase 2a, double-blind, 6-arm study for the treatment of primary focal segmental glomerulosclerosis (FSGS) or primary minimal change disease (MCD). The purpose of this study is to measure the change in proteinuria and its impact on the rates of remission of nephrotic syndrome with frexalimab, SAR442970, or rilzabrutinib compared with placebo in participants with primary FSGS or primary MCD aged 16 to 75 years. Study details for each participant include: The study duration... Read More

Gender:

ALL

Ages:

Between 16 years and 75 years

Trial Updated:

07/24/2025

Locations: Investigational Site Number: 8400007, Birmingham, Alabama +54 locations

Investigational Site Number: 8400007, Birmingham, Alabama

Investigational Site Number : 8400015, Orange, California

Investigational Site Number : 8400012, San Francisco, California

Investigational Site Number : 8400014, Chicago, Illinois

Investigational Site Number : 8400017, Hinsdale, Illinois

Investigational Site Number : 8400010, Ann Arbor, Michigan

Investigational Site Number : 8400019, Edina, Minnesota

Investigational Site Number : 8400018, Las Vegas, Nevada

Investigational Site Number : 8400001, New York, New York

Investigational Site Number : 8400005, El Paso, Texas

Investigational Site Number: 8400016, Houston, Texas

Investigational Site Number : 0320002, Cordoba, Córdoba

Investigational Site Number : 0320001, Buenos Aires, Not set

Investigational Site Number : 0360003, Canberra, Australian Capital Territory

Investigational Site Number : 0360001, Parkville, Victoria

Investigational Site Number : 0760002, Sao Paulo, São Paulo

Investigational Site Number: 0760001, São Paulo, Not set

Investigational Site Number : 1240001, Montreal, Quebec

Investigational Site Number : 1240006, Quebec City, Quebec

Investigational Site Number : 1520002, Santiago, Reg Metropolitana De Santiago

Investigational Site Number : 1520003, Temuco, Not set

Investigational Site Number : 1560001, Beijing, Not set

Investigational Site Number : 1560003, Chengdu, Not set

Investigational Site Number : 1560004, Shanghai, Not set

Investigational Site Number : 2030002, Olomouc, Not set

Investigational Site Number : 2030001, Prague, Not set

Investigational Site Number : 2500002, Créteil, Not set

Investigational Site Number : 2500001, Paris, Not set

Investigational Site Number : 2760002, Berlin, Not set

Investigational Site Number : 2760003, Hannover, Not set

Investigational Site Number : 3000002, Athens, Not set

Investigational Site Number : 3000001, Heraklion, Not set

Investigational Site Number : 3480001, Budapest, Not set

Investigational Site Number : 3800002, Florence, Firenze

Investigational Site Number : 3800003, Naples, Napoli

Investigational Site Number : 3800001, Brescia, Not set

Investigational Site Number : 4840001, Mexico City, Ciudad De Mexico

Investigational Site Number : 4840003, Monterrey, Nuevo León

Investigational Site Number : 5280001, Amsterdam, Not set

Investigational Site Number : 6160002, Opole, Not set

Investigational Site Number : 6200001, Matosinhos, Not set

Investigational Site Number : 6200002, Porto, Not set

Investigational Site Number : 7030003, Banská Bystrica, Not set

Investigational Site Number : 7030001, Martin, Not set

Investigational Site Number : 7240001, Barcelona, Barcelona [Barcelona]

Investigational Site Number : 7240004, Barcelona, Catalunya [Cataluña]

Investigational Site Number : 7240005, Seville, Sevilla

Investigational Site Number : 7240002, Córdoba, Not set

Investigational Site Number : 7240003, Valencia, Not set

Investigational Site Number : 1580001, Taichung, Not set

Investigational Site Number : 1580002, Taipei City, Not set

Investigational Site Number : 7920001, Izmit, Not set

Investigational Site Number : 7920002, Kayseri, Not set

Investigational Site Number : 8260001, Leicester, Leicestershire

Investigational Site Number : 8260004, Salford, Manchester

Conditions: Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion

Learn More ›

International CRDS Registry

NCT06508164

Recruiting

Calcium Release Deficiency Syndrome (CRDS) is a newly discovered genetic arrhythmia syndrome that confers a risk of life-threatening arrhythmias secondary to RYR2 loss-of-function. The International CRDS registry has been designed to facilitate large-scale evaluation of CRDS, including its phenotypic spectrum, approaches to risk stratification, and optimal treatment strategies.

Gender:

ALL

Ages:

All

Trial Updated:

07/24/2025

Locations: University of California, San Francisco, California +7 locations

Conditions: Calcium Release Deficiency Syndrome

Learn More ›

EXtubation Related Complications - the EXTUBE Study (EXTUBE)

NCT06442930

Recruiting

EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and describing clinical practices related to extubation after general anesthesia or after critical illness in the operating room (OR), out of OR anesthesia location or intensive care unit (ICU).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/24/2025

Locations: Oregon Health & Science University, Portland, Oregon +2 locations

Conditions: Extubation

Learn More ›

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

NCT07011732

Recruiting

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC in adult participants with agitation related to Alzheimer's Disease.

Gender:

ALL

Ages:

Between 55 years and 90 years

Trial Updated:

07/24/2025

Locations: Imaging Endpoints, Scottsdale, Arizona +125 locations

Imaging Endpoints, Scottsdale, Arizona

Local Institution - 1657, Anaheim, California

Local Institution - 1637, La Jolla, California

Local Institution - 1662, Pomona, California

Local Institution - 1639, Torrance, California

Local Institution - 1651, Walnut Creek, California

Local Institution - 1630, Colorado Springs, Colorado

Local Institution - 1622, Maitland, Florida

Local Institution - 1631, Maitland, Florida

Local Institution - 1618, Miami, Florida

Local Institution - 1609, Miami, Florida

Local Institution - 1604, Miami, Florida

Local Institution - 1608, Ocala, Florida

Local Institution - 1635, Orlando, Florida

Local Institution - 1612, Port Orange, Florida

Local Institution - 1661, Savannah, Georgia

Local Institution - 1655, Marrero, Louisiana

CBH Health, Gaithersburg, Maryland

Local Institution - 1638, Newton, Massachusetts

Local Institution - 1642, South Dartmouth, Massachusetts

Local Institution - 1660, Springfield, Massachusetts

Local Institution - 1620, Troy, Michigan

Local Institution - 1649, Las Vegas, Nevada

Local Institution - 1647, Middletown, New Jersey

Local Institution - 1610, Inwood, New York

Local Institution - 1656, New Windsor, New York

Local Institution - 1645, Woodmere, New York

Local Institution - 1658, Woodmere, New York

Local Institution - 1601, Monroe, North Carolina

Local Institution - 1659, Centerville, Ohio

Central States Research, Tulsa, Oklahoma

Local Institution - 1652, Columbia, South Carolina

Local Institution - 1653, Columbia, South Carolina

Local Institution - 1643, El Paso, Texas

Local Institution - 1641, Salt Lake City, Utah

Local Institution - 1646, Bennington, Vermont

Local Institution - 1644, Seattle, Washington

Local Institution - 1654, Spokane, Washington

Local Institution - 1001, La Plata, Buenos Aires

Local Institution - 1002, Mar del Plata, Buenos Aires

Local Institution - 1006, Rosario, Santa Fe

Local Institution - 1003, Buenos Aires, Not set

Local Institution - 1005, Cordoba, Not set

Local Institution - 1000, Cordoba, Not set

Local Institution - 1004, Córdoba, Not set

Local Institution - 1051, Brasília, Distrito Federal

Local Institution - 1053, Curitiba, Paraná

Local Institution - 1052, Curitiba, Paraná

Local Institution - 1054, Porto Alegre, Rio Grande Do Sul

Local Institution - 1056, Sao Paulo, SP

Local Institution - 1050, Rio De Janeiro, Not set

Local Institution - 1055, São Paulo, Not set

Local Institution - 1100, Sofia, Sofia-Grad

Local Institution - 1101, Pleven, Not set

Local Institution - 1103, Razgrad, Not set

Local Institution - 1102, Varna, Not set

Local Institution - 1153, Hamilton, Ontario

Local Institution - 1151, Toronto, Ontario

Local Institution - 1154, Toronto, Ontario

Local Institution - 1152, Whitby, Ontario

Local Institution - 1150, Montreal, Quebec

Local Institution - 1550, Zagreb, Grad Zagreb

Local Institution - 1553, Zagreb, Grad Zagreb

Local Institution - 1554, Rijeka, Not set

Local Institution - 1551, Split, Not set

Local Institution - 1552, Varazdin, Not set

Local Institution - 1200, Patras, Achaḯa

Local Institution - 1205, Athens, Attiki

Local Institution - 1202, Athens, Attiki

Local Institution - 1206, Athens, Not set

Local Institution - 1203, Athens, Not set

Local Institution - 1207, Athens, Not set

Local Institution - 1201, Ioannina, Not set

Local Institution - 1204, Thessaloniki, Not set

Local Institution - 1251, Hyderabad, Andhra Pradesh

Local Institution - 1255, Ahmedabad, Gujarat

Local Institution - 1252, Hyderabad, Telangana

Local Institution - 1254, Varanasi, Uttar Pradesh

Local Institution - 1250, Kolkata, West Bengal

Local Institution - 1256, Delhi, Not set

Local Institution - 1253, New Delhi, Not set

Local Institution - 1301, Hadano, Kanagawa

Local Institution - 1307, Kawasaki, Kanagawa

Local Institution - 1304, Sakai, Osaka

Local Institution - 1300, Karatsu-shi, Saga-Ken

Local Institution - 1303, Kanzaki-Gun Yoshinogari-Cho, Saga

Local Institution - 1305, Bunkyo-ku, Tokyo

Local Institution - 1302, Fukuoka, Not set

Local Institution - 1306, Okayama, Not set

Local Institution - 1355, Saltillo, Coahuila

Local Institution - 1356, Ciudad de México, Distrito Federal

Local Institution - 1350, Monterrey, Nuevo León

Local Institution - 1361, Mexico City, Not set

Local Institution - 1363, Mexico City, Not set

Local Institution - 1360, Mexico City, Not set

Local Institution - 1362, San Luis Potosi, Not set

Local Institution - 1352, Tlalnepantla de Baz, Not set

Local Institution - 1401, Coimbra, Not set

Local Institution - 1402, Guimaraes, Not set

Local Institution - 1404, Lisboa, Not set

Local Institution - 1403, Senhora da Hora, Not set

Local Institution - 1400, Torres Vedras, Not set

Local Institution - 1459, Bucharest, București

Local Institution - 1450, Bucuresti, București

Local Institution - 1452, Bucuresti, București

Local Institution - 1453, Bucuresti, București

Local Institution - 1454, Bucuresti, București

Local Institution - 1455, Bucuresti, București

Local Institution - 1456, Bucuresti, București

Local Institution - 1458, Bucuresti, București

Local Institution - 1451, Bucuresti, Not set

Local Institution - 1461, Constanta, Not set

Local Institution - 1457, Iasi, Not set

Local Institution - 1460, Sanpetru /Brasov, Not set

Local Institution - 1462, Sibiu, Not set

Local Institution - 1510, Getxo, Bizkaia

Local Institution - 1509, Elche (alicante), Not set

Local Institution - 1508, Madrid, Not set

Local Institution - 1505, Madrid, Not set

Local Institution - 1502, Malaga, Not set

Local Institution - 1507, Pamplona, Not set

Local Institution - 1500, Salamanca, Not set

Local Institution - 1503, Sevilla, Not set

Local Institution - 1504, Terrassa, Not set

Local Institution - 1506, Valladolid, Not set

Local Institution - 1501, Zaragoza, Not set

Conditions: Alzheimer Disease

Learn More ›

A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)

NCT06140836

Recruiting

The purpose of this study is to evaluate the efficacy and safety of repotrectinib and crizotinib in participants with locally advanced or metastatic TKI-naïve ROS1-positive non-small cell lung cancer (NSCLC).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/24/2025

Locations: Local Institution - 0136, Augusta, Georgia +143 locations

Local Institution - 0136, Augusta, Georgia

Local Institution - 0221, Des Moines, Iowa

Massachusetts General Hospital, Boston, Massachusetts

Beth Israel Deaconess Medical Center, Boston, Massachusetts

Local Institution - 0217, Brooklyn, New York

Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola, New York

Laura and Isaac Perlmutter Cancer Center, New York, New York

Local Institution - 0127, Syracuse, New York

Local Institution - 0214, Tacoma, Washington

Local Institution - 0061, Milwaukee, Wisconsin

Local Institution - 0092, Ciudad autónoma de Buenos Aires, Buenos Aires

Instituto Alexander Fleming, Ciudad Autónoma de Buenos Aires, Buenos Aires

Local Institution - 0091, ABB, Ciudad Autónoma De Buenos Aires

Local Institution - 0106, Buenos Aires, Not set

Local Institution - 0207, Buenos Aires, Not set

Instituto Oncológico de Córdoba, Córdoba, Not set

Local Institution - 0041, Wien, Not set

Hospital Luxemburgo, Belo Horizonte, Minas Gerais

Centro Gaucho Integrado De Oncologia, Hematologia, Ensino E Pesquisa, Porto Alegre, Rio Grande Do Sul

Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul

Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, São Paulo

Hospital Sírio Libanês, Sao Paulo, São Paulo

Hospital Paulistano, Sao Paulo, São Paulo

Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo

Hospital São Lucas de Copacabana, Rio de Janeiro, Not set

Centro de Tratamento de Tumores Botafogo para Oncoclinicas Rio de Janeiro SA, Rio de Janeiro, Not set

Instituto D'Or de Pesquisa e Ensino (IDOR), São Paulo, Not set

Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo, Not set

Local Institution - 0002, Toronto, Ontario

Local Institution - 0123, Trois-Rivières, Quebec

Fundacion Arturo Lopez Perez (FALP), Santiago, Región Metropolitana De Santiago

Oncocentro Apys, Viña del Mar, Valparaíso

Local Institution - 0168, Beijing, Beijing

Local Institution - 0185, Chongqing, Chongqing

Local Institution - 0192, Fuzhou, Fujian

Local Institution - 0169, Xiamen, Fujian

Local Institution - 0180, Guangzhou, Guangdong

Local Institution - 0194, Nanning, Guangxi

Local Institution - 0171, Harbin, Heilongjiang

Local Institution - 0166, Zhengzhou, Henan

Local Institution - 0181, Wuhan Shi, Hubei

Local Institution - 0203, Wuhan, Hubei

Local Institution - 0184, Changsha, Hunan

Local Institution - 0165, Changsha, Hunan

Local Institution - 0193, Nanjing, Jiangsu

Local Institution - 0202, Nanchang, Jiangxi

Local Institution - 0178, Changchun, Jilin

Local Institution - 0183, Xi'an, Shaanxi

Local Institution - 0186, Jinan, Shandong

Local Institution - 0205, Linyi, Shandong

Local Institution - 0164, Shanghai, Shanghai

Local Institution - 0179, Shanghai, Shanghai

Local Institution - 0170, Chengdu, Sichuan

Local Institution - 0177, Chengdu, Sichuan

Local Institution - 0204, Kunming, Yunnan

Local Institution - 0206, Hangzhou, Zhejiang

Local Institution - 0175, Hangzhou, Zhejiang

Nouvel Hôpital Civil (NHC), Strasbourg, Alsace

CHU Bordeaux Haut-Leveque, Pessac, Aquitaine

Centre Georges François Leclerc, Dijon, Côte-d'Or

CHU Charles Nicolle, Rouen, Haute-Normandie

Chu Grenoble Alpes, La Tronche, Isère

Hôpital Nord Guillaume-et-René-Laennec / CHU de Nantes, Saint-Herblain, Loire-Atlantique

Centre Hospitalier Lyon Sud, Pierre-Bénite, Rhône

Hopitaux Universitaires Paris Centre-Hopital Cochin, Paris, Not set

Klinikum Esslingen, Esslingen, Baden-Württemberg

Klinikum Würzburg Mitte, Wuerzburg, Bayern

Pius Hospital Oldenburg, Oldenburg, Niedersachsen

Evangelische Lungenklinik Berlin, Berlin, Not set

Local Institution - 0035, Dresden, Not set

Asklepios Klinik Gauting GmbH, Gauting, Not set

Lungenfachklinik Immenhausen, Immenhausen, Not set

Universitaetsklinikum Koeln, Köln, Not set

Marienhaus Klinikum Mainz, Mainz, Not set

University Hospital of Patras, Patras, Achaḯa

Thoracic General Hospital of Athens "I Sotiria", Athens, Attikí

Attikon General University Hospital, Chaidari, Attikí

"Theagenio" Cancer Hospital of Thessaloniki, Thessaloniki, Kentrikí Makedonía

Országos Korányi Pulmonológiai Intézet, Budapest, Not set

All India Institute of Medical Sciences, New Delhi, Delhi

Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, Delhi

Hemato Oncology Clinic, Ahmedabad, Gujarat

HCG Aastha Cancer Centre, Ahmedabad, Gujarat

Local Institution - 0117, Gurgaon, Haryana

Artemis hospital, Gurugram, Haryana

Manipal Hospitals, Bengaluru, Karnataka

Local Institution - 0219, Thiruvananthapuram, Kerala

Local Institution - 0065, Mumbai, Maharashtra

Local Institution - 0048, Mumbai, Maharashtra

Grant Medical Foundation - Ruby Hall Clinic, Pune, Maharashtra

Sahyadri Super Speciality Hospital, Pune, Maharashtra

Local Institution - 0220, Hyderabad, Telangana

Cro-Irccs, Aviano, Friuli-Venezia Giulia

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Lombardia

Fondazione IRCCS San Gerardo dei Tintori, Monza, Lombardia

A.O.R.N. Ospedale dei Colli - Monaldi V., Naples, Napoli

Istituto Nazionale Tumori Regina Elena, Rome, Roma

Nagoya University Hospital, Nagoya, Aichi

National Cancer Center Hospital East, Kashiwa, Chiba

National Hospital Organization Shikoku Cancer Center, Matsuyama-shi, Ehime

Hokkaido University Hospital, Sapporo, Hokkaido

Kanagawa cancer center, Yokohama, Kanagawa

Sendai Kosei Hospital, Sendai, Miyagi

Tokyo Metropolitan Komagome Hospital, Bunkyo ku, Tokyo

Tottori University Hospital, Yonago, Tottori

National Hospital Organization Kyushu Cancer Center, Fukuoka, Not set

Osaka City General Hospital, Osaka, Not set

Osaka International Cancer Institute, Osaka, Not set

Tokyo Metropolitan Police Hospital, Tokyo, Not set

Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do [Chungbuk]

Seoul National University Bundang Hospital, Seongnam, Kyǒnggi-do

Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul]

Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]

Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]

Local Institution - 0223, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur

Local Institution - 0237, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur

Local Institution - 0222, Lembah Pantai, Wilayah Persekutuan Kuala Lumpur

Local Institution - 0226, Lembah Pantai, Wilayah Persekutuan Kuala Lumpur

Local Institution - 0224, Putrajaya, Wilayah Persekutuan Kuala Lumpur

Amsterdam UMC, locatie VUmc, Amsterdam, Noord-Holland

Local Institution - 0215, Groningen, Not set

Local Institution - 0187, Lublin, Lubelskie

Warmińsko - Mazurskie Centrum Chorób Płuc w Olsztynie, Olsztyn, Warmińsko-mazurskie

SC Memorial Healthcare International SRL, Bucharest, București

Institutul Oncologic Bucuresti, Bucharest, București

Centrul de Oncologie "Sfântul Nectarie", Craiova, Dolj

Institutul Oncologic Cluj, Cluj, Not set

S.C. Centrul de Oncologie Euroclinic S.R.L., Iași, Not set

CHUAC-Hospital Teresa Herrera, A Coruña, A Coruña [La Coruña]

CHUS - Hospital Clinico Universitario, Santiago de Compostela, A Coruña [La Coruña]

Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona]

Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad De

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Comunidad De

H.R.U Málaga - Hospital General, Málaga, Not set

Hospital Universitario Virgen Del Rocio, Sevilla, Not set

Hospital Universitari i Politecnic La Fe, València, Not set

Kantonspital Baden, Baden, Aargau

Ankara Bilkent Şehir Hastanesi, Yenimahalle, Ankara

Adana Medical Park Seyhan Hastanesi, Adana, Not set

Sbü Gülhane Eğitim Ve Araştirma Hastanesi, Ankara, Not set

Medipol Mega Universite Hastanesi, Istanbul, Not set

T.C. Saglik Bakanligi Turkiye Kamu Hastaneleri Kurumu - Bakirkoy Dr. Sadi Konuk Egitim ve Arastirma Hastanesi, Istanbul, Not set

VM Medical Park Pendik Hospital, Istanbul, Not set

Sakarya Training and Research Hospital, Sakarya, Not set

Conditions: Carcinoma, Non-Small-Cell Lung

Learn More ›

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

NCT04368559

Recruiting

The purpose of this pivotal study is to determine if intravenous Rezafungin is efficacious and safe in the prevention of invasive fungal diseases when compared to the standard antimicrobial regimen.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/24/2025

Locations: University of Alabama at Birmingham, Birmingham, Alabama +50 locations

University of Alabama at Birmingham, Birmingham, Alabama

UCLA Center for Health Sciences, Los Angeles, California

Stanford University School of Medicine, Stanford, California

Augusta University Medical Center, Augusta, Georgia

Rush University Medical Center, Chicago, Illinois

University of Chicago, Chicago, Illinois

University of Maryland Medical Center, Baltimore, Maryland

Massachusetts General Hospital, Boston, Massachusetts

University of Minnesota Physicians, Minneapolis, Minnesota

Mayo Clinic, Rochester, Minnesota

Mary Hitchcock Memorial Hospital Dartmouth-Hitchcock, Lebanon, New Hampshire

Hackensack University Medical Center, Hackensack, New Jersey

Stony Brook University Hospital, Stony Brook, New York

The University of Oklahoma College of Medicine, Oklahoma City, Oklahoma

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

VCU Medical Center Main Hospital, Richmond, Virginia

Fred Hutchinson Cancer Center, Seattle, Washington

AZ Sint-Jan, Brugge, West Vlaanderen

University Hospitals Leuven, Campus Gasthuisberg - UZ Leuven, Leuven, Not set

Hamilton Health Sciences' Juravinski Hospital, Hamilton, Not set

McGill University Health Center, Montréal, Not set

Jean Minjoz Hospital, Besançon, Not set

Henri Mondor Hospital, Créteil, Not set

Grenoble Alpes University Hospital Center, Grenoble, Not set

University Hospital of Limoges, Limoges, Not set

University Hospital of Nantes, Nantes, Not set

Hospital Saint Antoine Ap-Hp, Paris, Not set

University Hospital of Bordeaux, Pessac, Not set

Lyon-Sud Hospital Center, Pierre-Bénite, Not set

University Hospital Carl Gustav Carus Dresden, Dresden, Not set

Essen University Hospital, Essen, Not set

University Hospital of Cologne, Köln, Not set

Johannes Gutenberg University Medical Center, Mainz, Not set

University Hospital Münster, Münster, Not set

San Martino Polyclinic Hospital, Genova, Not set

IEO Istituto Europeo di Oncologia, Milan, Not set

Agostino Gemelli University Policlinic, Rome, Not set

Humanitas Cancer Center, Rozzano, Not set

University Hospital Vall d'Hebron, Barcelona, Not set

Hospital Clinic of Barcelona, Barcelona, Not set

Hospital de la Princesa, Madrid, Not set

University Hospital Ramon y Cajal, Madrid, Not set

Puerta de Hierro Majadahonda University Hospital, Majadahonda, Not set

University Hospital of Salamanca, Salamanca, Not set

University Hospital of Valencia, Valencia, Not set

La Fe University and Polytechnic Hospital, Valencia, Not set

University Hospitals Geneva, Geneva, Not set

Hacettepe University School of Medicine, Ankara, Not set

Ankara University School of Medicine, Ankara, Not set

Addenbrookes Hospital, Cambridge, Not set

Kings College Hospital NHS Foundation Trust, London, Not set

Conditions: Candidemia, Mycoses, Fungal Infection, Fungemia, Invasive Candidiasis, Pneumocystis, Mold Infection, Invasive Fungal Disease, Prophylaxis of Invasive Fungal Infections, Aspergillus

Learn More ›

Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

NCT05953337

Recruiting

This is a prospective, multi-center, open-label study to evaluate the effectiveness and safety of Eye90 microspheres® in the treatment of subjects with unresectable Hepatocellular Carcinoma (HCC). Eye90 microspheres is a medical device containing yttrium-90 (Y-90), a radioactive material, and provides local radiation brachytherapy for the treatment of liver tumors.

Gender:

ALL

Ages:

Between 18 years and 99 years

Trial Updated:

07/23/2025

Locations: The University of Arizona Cancer Center, Tucson, Arizona +20 locations

Conditions: Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer

Learn More ›

Incomplete Cervical SCI Without Instability

NCT05653206

Recruiting

A multicenter, international, prospective, observational case series patient cohort with incomplete cervical SCI without instability will be enrolled to obtain information and data that could inform the feasibility of administering a set of additional core and optional outcome assessments in cervical SCI patients to capture the aspects of neurologic impairment. Baseline, intraoperative, and postoperative characteristics, including demographics, injury details, treatment details, neurological ass... Read More

Gender:

ALL

Ages:

Between 18 years and 80 years

Trial Updated:

07/23/2025

Locations: San Francisco General Hospital, San Francisco, California +9 locations

Conditions: Cervical Spinal Cord Injury

Learn More ›

Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment

NCT06041152

Recruiting

The goal of this clinical trial is to investigate the effects of psilocybin on synaptic vesicular density (SVD) as measured by the positron emission tomography (PET) radiotracer, 18F-SynVesT-1, in participants with amnestic Mild Cognitive Impairment (aMCI) and healthy participants. The investigators hypothesize that SVD levels in the brain will be higher following the ingestion of psilocybin in comparison to placebo, and that increases in SVD will be associated with improvements in cognition. 6... Read More

Gender:

ALL

Ages:

Between 60 years and 75 years

Trial Updated:

07/23/2025

Locations: Centre for Addiction and Mental Health, Toronto, Ontario

Conditions: Amnestic Mild Cognitive Impairment

Learn More ›

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

NCT05211895

Recruiting

This is a Phase III, randomised, double-blind, placebo-controlled, multicentre, international study assessing the efficacy and safety of durvalumab (MEDI4736) and domvanalimab (AB154) compared with durvalumab plus placebo in adults with locally advanced (Stage III), unresectable NSCLC whose disease has not progressed following definitive platinum-based cCRT.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/23/2025

Locations: Research Site, Chandler, Arizona +257 locations

Research Site, Chandler, Arizona

Research Site, Phoenix, Arizona

Research Site, Fountain Valley, California

Research Site, Santa Rosa, California

Research Site, Washington, District of Columbia

Research Site, Jacksonville, Florida

Research Site, Orlando, Florida

Research Site, Saint Augustine, Florida

Research Site, Macon, Georgia

Research Site, Elmhurst, Illinois

Research Site, Maywood, Illinois

Research Site, Naperville, Illinois

Research Site, Louisville, Kentucky

Research Site, Baltimore, Maryland

Research Site, Silver Spring, Maryland

Research Site, Detroit, Michigan

Research Site, Minneapolis, Minnesota

Research Site, Rochester, Minnesota

Research Site, Reno, Nevada

Research Site, East Brunswick, New Jersey

Research Site, Florham Park, New Jersey

Research Site, Buffalo, New York

Research Site, Johnson City, New York

Research Site, Asheville, North Carolina

Research Site, Charlotte, North Carolina

Research Site, Winston-Salem, North Carolina

Research Site, Columbus, Ohio

Research Site, Oklahoma City, Oklahoma

Research Site, Pittsburgh, Pennsylvania

Research Site, Charleston, South Carolina

Research Site, Nashville, Tennessee

Research Site, Fort Sam Houston, Texas

Research Site, Kingwood, Texas

Research Site, Arlington, Virginia

Research Site, Fort Belvoir, Virginia

Research Site, Spokane Valley, Washington

Research Site, Appleton, Wisconsin

Research Site, Brussels, Not set

Research Site, Edegem, Not set

Research Site, Haine-Saint-Paul, Not set

Research Site, Leuven, Not set

Research Site, Liege, Not set

Research Site, Sint-Niklaas, Not set

Research Site, Barretos, Not set

Research Site, Londrina, Not set

Research Site, Porto Alegre, Not set

Research Site, Porto Velho, Not set

Research Site, Rio de Janeiro, Not set

Research Site, Santo Andre, Not set

Research Site, Sao Paulo, Not set

Research Site, São Paulo, Not set

Research Site, Taubaté, Not set

Research Site, Calgary, Alberta

Research Site, Kelowna, British Columbia

Research Site, Laval, Quebec

Research Site, Montréal, Quebec

Research Site, Las Condes, Not set

Research Site, Puerto Montt, Not set

Research Site, Santiago, Not set

Research Site, Temuco, Not set

Research Site, Aix en Provence, Not set

Research Site, Angers, Not set

Research Site, Bobigny, Not set

Research Site, Clermont-Ferrand, Not set

Research Site, Lille, Not set

Research Site, Paris Cedex 14, Not set

Research Site, Pau cedex, Not set

Research Site, Quimper, Not set

Research Site, Saint Gregoire, Not set

Research Site, Saint-Quentin cedex, Not set

Research Site, Vantoux, Not set

Research Site, Villeurbanne, Not set

Research Site, Berlin-Zehlendorf, Not set

Research Site, Berlin, Not set

Research Site, Braunschweig, Not set

Research Site, Chemnitz, Not set

Research Site, Erlangen, Not set

Research Site, Essen, Not set

Research Site, Georgsmarienhuette, Not set

Research Site, Giessen, Not set

Research Site, Halle, Not set

Research Site, Hamburg, Not set

Research Site, Homburg, Not set

Research Site, Koblenz, Not set

Research Site, Krefeld, Not set

Research Site, Köln, Not set

Research Site, Löwenstein, Not set

Research Site, Moers, Not set

Research Site, München, Not set

Research Site, Regensburg, Not set

Research Site, Tübingen, Not set

Research Site, Athens, Not set

Research Site, Holargos, Athens, Not set

Research Site, Thessaloniki, Not set

Research Site, Hong Kong, Not set

Research Site, Budapest, Not set

Research Site, Deszk, Not set

Research Site, Győr, Not set

Research Site, Salgótarján, Not set

Research Site, Székesfehérvár, Not set

Research Site, Törökbálint, Not set

Research Site, Ahmedabad, Not set

Research Site, Bangalore, Not set

Research Site, Delhi, Not set

Research Site, Gurgaon, Not set

Research Site, Howrah, Not set

Research Site, Hyderabad, Not set

Research Site, Jaipur, Not set

Research Site, Kolkata, Not set

Research Site, Marg Jaipur, Not set

Research Site, Mohali, Not set

Research Site, Namakkal, Not set

Research Site, New Delhi, Not set

Research Site, Varanasi, Not set

Research Site, Bergamo, Not set

Research Site, Roma, Not set

Research Site, Rozzano, Not set

Research Site, Udine, Not set

Research Site, Bunkyo-ku, Not set

Research Site, Chiba-shi, Not set

Research Site, Fukuoka-shi, Not set

Research Site, Hidaka-shi, Not set

Research Site, Hirosaki-shi, Not set

Research Site, Itabashi-ku, Not set

Research Site, Kashihara-shi, Not set

Research Site, Koto-ku, Not set

Research Site, Kumamoto-shi, Not set

Research Site, Matsuyama-shi, Not set

Research Site, Nagoya-shi, Not set

Research Site, Osaka-shi, Not set

Research Site, Osakasayama-shi, Not set

Research Site, Sapporo-shi, Not set

Research Site, Sunto-gun, Not set

Research Site, Tokyo, Not set

Research Site, Yokohama-shi, Not set

Research Site, Daegu, Not set

Research Site, Goyang-si, Not set

Research Site, Incheon, Not set

Research Site, Jinju-si, Not set

Research Site, Seoul, Not set

Research Site, Suwon, Not set

Research Site, Johor Bahru, Not set

Research Site, Kuala Lumpur, Not set

Research Site, Kuching, Not set

Research Site, Selangor, Not set

Research Site, Aguascalientes, Not set

Research Site, Cdmx, Not set

Research Site, Chihuahua, Not set

Research Site, Guadalajara, Not set

Research Site, Monterrey, Not set

Research Site, Oaxaca, Not set

Research Site, San Pedro Garza Garcia, Not set

Research Site, Sonora, Not set

Research Site, Veracruz, Not set

Research Site, Bodø, Not set

Research Site, Gjøvik, Not set

Research Site, Oslo, Not set

Research Site, Trondheim, Not set

Research Site, Bacolod, Not set

Research Site, Iloilo City, Not set

Research Site, Muntinlupa City, Not set

Research Site, Pasig City, Not set

Research Site, Quezon City, Not set

Research Site, Białystok, Not set

Research Site, Gliwice, Not set

Research Site, Katowice, Not set

Research Site, Warszawa, Not set

Research Site, Wroclaw, Not set

Research Site, Zielona Góra, Not set

Research Site, Łódź, Not set

Research Site, Bucuresti, Not set

Research Site, Craiova, Not set

Research Site, Floresti, Not set

Research Site, Iasi, Not set

Research Site, Oradea, Not set

Research Site, Sibiu, Not set

Research Site, Suceava, Not set

Research Site, Timisoara, Not set

Research Site, Amanzimtoti, Not set

Research Site, Cape Town, Not set

Research Site, Johannesburg, Not set

Research Site, Parktown, Not set

Research Site, Pretoria, Not set

Research Site, Bilbao (Vizcaya), Not set

Research Site, Castello de la Plana, Not set

Research Site, Córdoba, Not set

Research Site, El Palmar, Not set

Research Site, Palma de Mallorca, Not set

Research Site, Sabadell (Barcelona), Not set

Research Site, Basel, Not set

Research Site, Bern, Not set

Research Site, Lausanne, Not set

Research Site, Hsinchu, Not set

Research Site, New Taipei, Not set

Research Site, Taichung, Not set

Research Site, Tainan, Not set

Research Site, Taipei, Not set

Research Site, Taoyuan, Not set

Research Site, Bangkok, Not set

Research Site, Hat Yai, Not set

Research Site, Adapazari, Not set

Research Site, Ankara, Not set

Research Site, Antalya, Not set

Research Site, Edirne, Not set

Research Site, Istanbul, Not set

Research Site, İstanbul, Not set

Research Site, Izmir, Not set

Research Site, Konya, Not set

Research Site, Çankaya, Not set

Research Site, Birmingham, Not set

Research Site, Brighton, Not set

Research Site, Cambridge, Not set

Research Site, Cardiff, Not set

Research Site, Cheltenham, Not set

Research Site, High Heaton/Newcastle Upon Tyn, Not set

Research Site, Leeds, Not set

Research Site, London, Not set

Research Site, Nottingham, Not set

Research Site, Truro, Not set

Research Site, Hanoi, Not set

Research Site, Ho Chi Minh city, Not set

Research Site, Ho Chi Minh, Not set

Conditions: Non-Small Cell Lung Cancer

Learn More ›